Rhythm Pharmaceuticals, Inc. (RYTM)
85.69
-2.17
(-2.47%)
USD |
NASDAQ |
Jun 10, 16:00
85.70
+0.01
(+0.01%)
After-Hours: 20:00
Rhythm Pharmaceuticals Gross Profit Margin (Quarterly) : 88.01% for March 31, 2026
Gross Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 88.01% |
| December 31, 2025 | 91.61% |
| September 30, 2025 | 89.08% |
| June 30, 2025 | 88.20% |
| March 31, 2025 | 88.33% |
| December 31, 2024 | 90.54% |
| September 30, 2024 | 87.97% |
| June 30, 2024 | 89.26% |
| March 31, 2024 | 88.45% |
| December 31, 2023 | 85.82% |
| September 30, 2023 | 88.26% |
| Date | Value |
|---|---|
| June 30, 2023 | 87.18% |
| March 31, 2023 | 85.49% |
| December 31, 2022 | 85.71% |
| September 30, 2022 | 83.08% |
| June 30, 2022 | 93.38% |
| March 31, 2022 | 69.96% |
| December 31, 2021 | 75.40% |
| September 30, 2021 | 58.85% |
| June 30, 2021 | -24.09% |
| March 31, 2021 | -485.7% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 90.75% |
| Biogen, Inc. | 63.99% |
| Regeneron Pharmaceuticals, Inc. | 78.02% |
| Vertex Pharmaceuticals, Inc. | 86.96% |
| AbbVie, Inc. | 71.93% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -242.5% |
| Return on Assets | -46.28% |
| Return on Invested Capital | -60.86% |
| Profit Margin (Quarterly) | -92.56% |
| Operating Margin (Quarterly) | -87.11% |
| Return on Net Operating Assets | -322.0% |